← All trials
NCT05587894
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 31, 2022
- Primary completion
- Jan 31, 2024
- Completion date
- Jan 31, 2025
- First posted
- Oct 20, 2022
- Last posted
- Oct 20, 2022
- Enrollment
- 256
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Government of FranceLead sponsor
- University of GenevaCollaborator
- University of GenevaReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.